Antinuclear antibody formation following administration of anti-tumor necrosis factor agents in Japanese patients with psoriasis

被引：5
|
作者：
Yanaba, Koichi [1 ]
Umezawa, Yoshinori [1 ]
Honda, Hiromi [1 ]
Sato, Reiko [1 ]
Chiba, Miki [1 ]
Kikuchi, Sota [1 ]
Asahina, Akihiko [1 ]
Nakagawa, Hidemi [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Dermatol, 3-25-8 Nishishimbashi, Tokyo 1058461, Japan
来源：
JOURNAL OF DERMATOLOGY | 2016年 / 43卷 / 04期
关键词：
ALPHA THERAPY; AUTOANTIBODIES; INFLIXIMAB;
D O I：
10.1111/1346-8138.13215
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：443 / 444
页数：2
相关论文
共 50 条
  • [1] The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents
    Ergun, Tulin
    Seckin, Dilek
    Bulbul, Emel Baskan
    Onsun, Nahide
    Ozgen, Zuleyha
    Unalan, Pemra
    Alpsoy, Erkan
    Karakurt, Sait
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (05) : 594 - 599
  • [2] The Use of Anti-Tumor Necrosis Factor Agents and Development of Psoriasis in Patients with Crohn's Disease
    Lin, Ming
    Blonski, Wojciech
    Weiner, Mark
    Tierney, Ann
    Marchioni, Renee
    Buchner, Anna
    Lichtenstein, Gary
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S490 - S491
  • [3] The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: A retrospective long-term study
    Saraceno, Rosita
    Specchio, Francesca
    Torres, Tiago
    Nistico, Steven Paul
    Rizza, Stefano
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : E180 - E182
  • [4] Thrombocytopenia associated with the use of anti-tumor necrosis factor-α agents for psoriasis
    Brunasso, Alexandra Maria Giovanna
    Massone, Cesare
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (05) : 781 - 785
  • [5] The impact of antinuclear antibodies seroconversion induced by anti-tumor necrosis factor α agents on the clinical outcomes in rheumatic patients
    Martins, A.
    Oliveira, D.
    Martins, F. R.
    Rato, M. S.
    Pinheiro, F. O.
    Fonseca, D.
    Garcia, S.
    Fernandes, B. M.
    Pimenta, S.
    Vaz C, Costa
    Bernardes, M.
    ARP RHEUMATOLOGY, 2023, 2 (02): : 120 - 131
  • [6] Responses to adalimumab in psoriasis patients previously treated with anti-tumor necrosis factor agents: Subanalysis of BELIEVE
    Ortonne, Jean-Paul
    Thaci, Diamant
    Goldblum, Orin
    Chimenti, Sergio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB130 - AB130
  • [7] Anti-tumor necrosis factor-α-induced psoriasis
    Sari, Ismail
    Akar, Servet
    Birlik, Merih
    Sis, Banu
    Onen, Fatos
    Akkoc, Nurullah
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (07) : 1411 - 1414
  • [8] Psoriasis Induced by Anti-Tumor Necrosis Factor Alpha Agents: A Comprehensive Review of the Literature
    Ciccarelli, Fedra
    De Martinis, Massimo
    Sirufo, Maria Maddalena
    Ginaldi, Lia
    ACTA DERMATOVENEROLOGICA CROATICA, 2016, 24 (03) : 169 - 174
  • [9] Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars
    Prignano, Francesca
    Choi, Jaeyun
    Pieper, Burkhard
    Iversen, Lars
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 75 - 80
  • [10] Effects of anti-tumor necrosis factor a agents on bone
    Kawai, Vivian K.
    Stein, C. Michael
    Perrien, Daniel S.
    Griffin, Marie R.
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (05) : 576 - 585
12345